In Case You Need More Evidence mRNA Injections Are NOT Vaccines
Study finds that five doses of the mRNA vaccination suppresses SARS-CoV2-specific cellular immunity
Studies are only now being performed to assess the immune response after repeated injections. This comes three years after the initial rollout of COVID genetic vaccines.
These studies should have been carried out prior to mass “vaccination” programs and global rollout of these genetic vaccines. Data now shows what immunologist have feared, that the genetic vaccines are not as effective as they were touted at the outset of the rollout. Not only does immunity quickly wane after administration but, immunity is being skewed towards tolerance after repeated injections.
Tolerance is the prevention of an immune response against a particular antigen.
Concerns over fast-tracking the COVID “vaccine” program included compromised assessments of immunological memory
An article that came out in July 2020 raised concerns about fast-tracking a vaccine against SARS-CoV-2. One concern that was raised was about immunity–are antibodies protective and how long does immunity last?
Source: © John Holcroft/Ikon Images
The multitude of vaccines in development give us many shots at a potentially useful vaccine. But rushed development could mean missing information about long-term safety and protection
‘Arguably, a vaccine against Covid-19 should confer immunity for more than one year to reduce the risk of future recurrences. But how long would it take to determine if a vaccine can confer immunological memory for one year? Of course, it would take at least one year. So how does that fit into the goal of getting a vaccine into broad public use in under a year? A prophylactic vaccine is useless if it does not confer long-term immunological memory’ to respond when exposed to the virus stated Dr. Byram Bridle, a viral immunologist.
Foreshadowing of what was to come…..
The following is an excerpt from an affidavit I wrote in September 2021 for a lawsuit opposing the mandate for airline pilots. NOTE: This is only a portion of the expert testimony I provided but it is important background for the discussion on the recent findings on what happens after the fifth mRNA injection.
The harmful and long-term effects of the EUA COVID-19 mRNA injections, including COMIRNATY, are unknown.
While the use of mRNA as a potential vaccine platform has been explored since the 1990s, mRNA has never been successfully used to reduce the incidence of infectious disease in the history of man. In animal studies, mRNA ‘vaccines’ or products have not only repeatedly failed as viable therapies for the prevention or treatment of infectious disease, but have resulted in alarming organ injuries, systemic harm, and rapid death in animal subjects. The EUA COVID-19 ‘vaccines’ are first-in-human biological agents. The majority of animal trials required to determine if these products would be safe for human use were skipped under the FDA’s emergency use authorization. Neither we, nor the FDA, have any idea if the mRNA vaccines are safe for humans or what the long-term side effects will be.
Per the FDA’s own August 23, 2021, approval letter of the Pfizer-BioNTech COVID-19 Vaccine, COMIRNATY, the FDA is requiring the manufacturer to complete TEN (10) additional studies for adults to assess the risks of COMIRNATY, including but not limited to the risks of myocarditis (heart inflammation, congestive heart failure, and death), immunogenicity (unwanted immune responses that may result in permanent injuries, disease and/or death), and harm to babies who were EXPOSED to vaccinated individuals while inside their mother’s womb, resulting in birth defects, autoimmune disease, or death. For any new FDA approved product used in humans, safety testing always takes years before a new product is brought to market. The FDA typically requires these type of safety studies to be completed prior to FDA approval.
Per the VAERS database and independent clinical studies, the EUA COVID-19 injections, including COMIRNATY, are proven to be toxic and harmful with an unreasonably high-risk for permanent injuries and death.
mRNA is highly unstable and can easily disintegrate making transfection, introduction into a cell, difficult. The Pfizer and Moderna ‘vaccines’ consist of mRNA encapsulated in a protective lipid biosphere known as lipid nanoparticles, or LNPs. The LNPs are made of cholesterol, phospholipids, ionized lipids, and PEGylated lipids to protect the mRNA and facilitate its delivery to and penetration into T-cells for production of the spike proteins. The mRNA LNPs are highly inflammatory resulting in cytokine storms that can lead to permanent lung and heart damage, cancer, and/or death.
In general, mRNA is highly unstable and easily degradable thus modification with pseudouridine for uridine can increase translational capacity however, these unnatural nucleosides are themselves toxic. "The clinical adverse effects have included myopathy (caused by mitochondrial toxicity), lactic acidosis, pancreatitis, lipodystrophy, liver steatosis, and nerve damage; certain ones have been fatal." Liver toxicity was especially predominant in clinical trials with mRNA therapeutics especially when repeat dosing was used. "Nevertheless, this observed toxicity may be concerning for vaccines as well, since even live replicating viruses and viral vector vaccines (which generally are more immunogenic than subunit vaccines) need repeat dosing" (A Comparison of Plasmid DNA and mRNA as Vaccine Technologies).
mRNA alone is highly inflammatory given that double-stranded RNA stimulates the innate immune response via Toll-like receptors (TLR3, TLR7 and TLR8). Stimulation of these pathways can act to inhibit mRNA replication. In addition, mRNA ‘vaccines’ elicit an inflammatory type I interferon (IFN) response which is a standard immune response to viral infection. However, type I interferon responses can have a negative impact for mRNA ‘vaccines’ in that IFN can impair vaccine elicited adaptive immunity and thus their efficacy. This can lead to unwanted and harmful autoimmune responses to the mRNA via the induction of type I interferon. It is well-known that autoimmune disease occurs in some percentage subjects injected with traditional vaccines and is expected to be in much higher percentages with the new, first-in-human mRNA biological agents.
Furthermore, given the immune activation by mRNA...."Some of these various activities could decrease the potency of the mRNA by a net decreased protein production, as was seen pre-clinically for an HIV mRNA vaccine complexed in cationic lipids. This also raises the issue of how effective repeat dosing of mRNA will be if previous injections result in an environment with decreased translation or increased RNA degradation, although simply changing an injection site may potentially circumvent this particular issue."
**This information MUST NOT be ignored in light of the desire for repeat dosing with mRNA in the form of 'booster shots'.
The immune response is skewed towards tolerance after the third dose of mRNA
I had previously written about the skewing of the immune response following the third mRNA injection embedded in this post. Reason number four under why continued injections make no sense.
There is NO data on the effect of multiple sequential doses of mRNA injections. A new study recently came out showing that with each successive injection the immune response is being skewed towards immune tolerance!
"Here, we report that several months after the second vaccination, SARS-CoV-2-specific antibodies were increasingly composed of non-inflammatory IgG4, which were further boosted by a third mRNA vaccination and/or SARS-CoV-2 variant breakthrough infections."
The implications of this are quite disturbing. The role of IgG4 as a ‘tolerizing antibody’ is inherently linked to T regulatory cells (Tregs). Tregs are essential to the maintenance of immunological unresponsiveness to self-antigens thus protecting the host from unwanted immunological responses to self. What this means in laymen’s terms is increased potential for autoimmune diseases and cancers.
For more information on this topic:
A new study reveals that cellular (memory) immunity is diminished after the fifth injection of mRNA
First off, why are people even up to five injections of mRNA? Incredible to believe that in some countries people are up to their seventh injection. When in history of vaccinology has there been a requirement for 5 injections in two years? Hepatitis B vaccine requires three injections over the course of a year but then you are good for life. These mRNA injections are being treated as therapeutics only they aren’t treating anything.
A recent Japanese study examined the long-term cellular and humoral immune responses following the fifth administration of the mRNA vaccine in high-risk populations.
To the best of our knowledge, this is the first study to monitor long-term data on the dynamics of humoral and cellular immunity in high-risk populations following the administration of the five-dose mRNA vaccination regimen, including the bivalent mRNA vaccine.
A total of 61 individuals participated in this study. The median age was 70 years. Although most participants acquired humoral immunity, reduced cellular immune reactivity was observed in a subset of patients. Only 50% of individuals in the study maintained cellular immunity three months after the fifth dose.
Previously, in the same patients, the researchers reported that 71.4% (40/56) of individuals acquired cellular immunity two weeks after the third dose. In a healthy population, 64.3% (700/1089) of individuals acquired cellular immunity after the third dose. They observed an increase in the proportion of individuals unable to acquire cellular immunity after the fifth dose. These specific immune alterations might involve the Tregs expression or the emergence of exhausted T cells.
However, a consistent portion of the population remained unable to acquire cellular immunity even after the fifth dose, similar to the third dose.
The researchers conclude that considering the potential for immune tolerance and exhaustion in cellular immunity after repeated mRNA vaccine administration (especially five or more doses), there might be an alternative strategy for SARS-CoV-2 immunization. Further studies are needed to elucidate the efficacy of repeated vaccinations.